|
We asked 50 pharma leaders,  how do you think the reputation of the pharma industry has changed in recent years?
| Improved |
12% |
Stayed the same |
27% |
| Declined |
61% |
 |
|
|
|
|
|
|
|
12 March, 2013
|
| In this Issue |
Teva Changes Face of Top 10 Pharma
Teva's accession to the exclusive group that is the Pharma Top 10 is further proof, according to IMS Health, that branded pharma needs to renounce its product-protected past and embrace the patient-led, specialty-focused future ...Read more |
Good Gamification — It's Not Child’s Play
One of last year’s biggest buzzwords was “gamification” and that probably means that in 2013 there are a lot of people trying to sell you on the value of “gamifying” your pharma business. There’s a lot of value in there, but before you head off to commission your own “Pharmaville” app, you should know that good gamification isn’t child’s play ... Read more |
European Patents Filling Up, But Pharma Stays Flat
While the number of patent filings at the European Patent Office (EPO) in 2012 increased by 5.2% over 2011, pharmaceutical-based patents remained flat, and biotechnology patents dropped slightly, writes Rita Peters ... Read more |
Pharm Exec's Emerging Pharma Leaders 2013
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should receive Pharmaceutical Executive's Emerging Pharma Leadership Award. Fill out a nomination today ... Read more
|
|
|
|
